Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma ; volume:27 ; number:1 ; day:28 ; month:1 ; year:2021 ; pages:1-13 ; date:12.2021
Molecular medicine ; 27, Heft 1 (28.1.2021), 1-13, 12.2021
- Creator
-
Yuan, Qiuyun
Yang, Wanchun
Zhang, Shuxin
Li, Tengfei
Zuo, Mingrong
Zhou, Xingwang
Li, Junhong
Li, Mao
Xia, Xiaoqiang
Chen, Mina
Liu, Yanhui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-020-00261-4
- URN
-
urn:nbn:de:101:1-2021032120010417500791
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yuan, Qiuyun
- Yang, Wanchun
- Zhang, Shuxin
- Li, Tengfei
- Zuo, Mingrong
- Zhou, Xingwang
- Li, Junhong
- Li, Mao
- Xia, Xiaoqiang
- Chen, Mina
- Liu, Yanhui
- SpringerLink (Online service)
Other Objects (12)
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Glioma and temozolomide induced alterations in gut microbiome
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma
Butyrate suppresses demyelination and enhances remyelination
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Glioma and temozolomide induced alterations in gut microbiome
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma
Butyrate suppresses demyelination and enhances remyelination
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Glioma and temozolomide induced alterations in gut microbiome
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma
Butyrate suppresses demyelination and enhances remyelination
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model
Metalloproteases involved in the Temozolomide (TMZ) resistance of U87-MG glioma cells